Skip to main content
. Author manuscript; available in PMC: 2018 Jul 6.
Published in final edited form as: J Clin Lipidol. 2018 Mar 2;12(3):718–727.e6. doi: 10.1016/j.jacl.2018.02.010

Table S2. Risk of fatal events by Omega-3 Index (n = 2500).

Hazard ratios (95% CIs)
CVD mortality Cancer mortality Other mortality Any mortality
Omega-3 Index–unadjusted
 <4.2% (n = 508) 1.0 1.0 1.0 1.0
 4.2%–4.9% (n = 500) 0.97 (0.41, 2.30) 0.94 (0.58, 1.55) 0.59 (0.34, 1.02) 0.81 (0.59, 1.12)
 4.9%–5.7% (n = 501) 0.96 (0.43, 2.16) 0.88 (0.50, 1.57) 0.63 (0.36, 1.09) 0.78 (0.56, 1.10)
 5.7%–6.8% (n = 502) 1.10 (0.46, 2.62) 0.72 (0.42, 1.23) 0.67 (0.40, 1.11) 0.73 (0.53, 1.02)
 >6.8% (n = 489) 0.88 (0.39, 2.01) 1.19 (0.72, 1.97) 0.53 (0.31, 0.91) * 0.81 (0.58, 1.12)
P-value for linear trend .86 .85 .07 .16
Omega-3 Index–adjusted§
 <4.2% (n = 508) 1.0 1.0 1.0 1.0
 4.2%–4.9% (n = 500) 0.57 (0.23, 1.40) 0.66 (0.38, 1.14) 0.54 (0.31, 0.94) * 0.74 (0.53, 1.04)
 4.9%–5.7% (n = 501) 0.54 (0.20, 1.47) 0.73 (0.42, 1.28) 0.38 (0.20, 0.73) 0.67 (0.46, 0.96) *
 5.7%–6.8% (n = 502) 0.56 (0.22, 1.43) 0.60 (0.35, 1.03) 0.44 (0.25, 0.79) 0.59 (0.41, 0.86)
 >6.8% (n = 489) 0.39 (0.15, 1.02) 0.96 (0.56, 1.64) 0.44 (0.24, 0.79) 0.66 (0.45, 0.96) *
P-value for linear trend .10 .88 .009 .02 *

CVD, cardiovascular disease; CI, confidence interval.

*

P < .05

P < .01

P < .001.

All significant hazard ratios/P-values are shown in bold italics.

§

Adjusted for all variables in Table 1 except baseline CVD.